Bingya Liu Selected Research

Therapeutics

1/2019	Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy.
1/2019	Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2.
8/2017	The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer.
3/2017	IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
2/2017	microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
9/2015	Protecting the normal in order to better kill the cancer.
5/2015	Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer.
4/2015	Redox-responsive micelles self-assembled from dynamic covalent block copolymers for intracellular drug delivery.
1/2015	The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells.
1/2015	Characterization of differentially expressed genes involved in pathways associated with gastric cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingya Liu Research Topics

Disease

75	Stomach Neoplasms (Stomach Cancer) 04/2024 - 09/2004
72	Neoplasms (Cancer) 12/2023 - 09/2004
26	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
11	Carcinogenesis 04/2024 - 12/2010
6	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 12/2012
6	Breast Neoplasms (Breast Cancer) 01/2014 - 05/2010
4	Carcinoma (Carcinomatosis) 01/2020 - 05/2009
4	Lymphatic Metastasis 02/2018 - 02/2012
4	Colonic Neoplasms (Colon Cancer) 01/2015 - 09/2010
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2015
2	Residual Neoplasm 08/2017 - 04/2017
2	Laryngeal Neoplasms (Laryngeal Cancer) 08/2016 - 11/2011
2	Infections 10/2012 - 03/2011
2	Chromosomal Instability (Chromosome Stability) 02/2012 - 11/2011
1	Iron Overload 11/2023
1	Ascites 01/2021
1	Metaplasia 01/2020
1	Endotoxemia 01/2019

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2007
20	Biomarkers (Surrogate Marker)IBA 07/2021 - 02/2007
13	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 09/2010
13	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2010
8	Small Interfering RNA (siRNA)IBA 08/2017 - 05/2010
6	Long Noncoding RNAIBA 01/2021 - 04/2014
6	Messenger RNA (mRNA)IBA 07/2017 - 12/2011
5	CateninsIBA 02/2019 - 10/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 07/2013
3	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 04/2015
3	Histones (Histone)IBA 07/2015 - 09/2008
3	AgarIBA 02/2014 - 06/2012
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 10/2021
2	Androgen Receptors (Androgen Receptor)IBA 11/2023 - 11/2014
2	PlatinumIBA 01/2023 - 01/2019
2	LuciferasesIBA 01/2022 - 01/2014
2	CytokinesIBA 01/2020 - 05/2012
2	Indicators and Reagents (Reagents)IBA 01/2018 - 04/2017
2	Zinc Finger Protein GLI1IBA 04/2017 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 09/2013
2	Neutralizing AntibodiesIBA 03/2017 - 07/2013
2	Carcinoembryonic AntigenIBA 01/2017 - 04/2014
2	Cell Adhesion MoleculesIBA 01/2017 - 04/2014
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 05/2015
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2017 - 05/2015
2	Aurora Kinase AIBA 08/2016 - 11/2011
2	RNA (Ribonucleic Acid)IBA 03/2016 - 06/2010
2	ProteomeIBA 02/2016 - 02/2007
2	PaxillinIBA 05/2015 - 05/2014
2	Capecitabine (Xeloda)FDA Link 04/2015 - 07/2014
2	Claudin-1IBA 01/2015 - 04/2014
2	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 01/2015 - 09/2010
2	Blood Proteins (Serum Proteins)IBA 04/2014 - 09/2008
2	matrigelIBA 02/2014 - 01/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2013 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 09/2013 - 05/2010
2	ThioredoxinsIBA 12/2012 - 01/2011
2	Protein Tyrosine PhosphatasesIBA 06/2012 - 07/2010
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 06/2012 - 07/2010
2	AntigensIBA 05/2012 - 09/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011 - 06/2010
2	Protein Isoforms (Isoforms)IBA 08/2011 - 05/2009
1	fetal Alzheimer antigenIBA 12/2023
1	N-(6,7-difluoroquinolonyl)ampicillinIBA 12/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2023
1	IronIBA 11/2023
1	Lipid PeroxidesIBA 11/2023
1	CalponinsIBA 01/2023
1	anlotinibIBA 10/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2021
1	VimentinIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	Docetaxel (Taxotere)FDA Link 11/2020
1	Cathepsin LIBA 11/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2020
1	Vascular Endothelial Growth Factor DIBA 11/2020
1	Cytidine Diphosphate (CDP)IBA 11/2020
1	MucinsIBA 01/2020
1	spasmolytic polypeptideIBA 01/2020
1	Cell Surface ReceptorsIBA 02/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2019
1	AcidsIBA 02/2019
1	PalmitatesIBA 02/2019
1	Oncostatin MIBA 01/2019
1	CRKL proteinIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	AMP-Activated Protein KinasesIBA 01/2019
1	KinesinsIBA 01/2019
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 01/2019

Therapy/Procedure

13	Therapeutics 01/2019 - 09/2004
12	Drug Therapy (Chemotherapy) 01/2023 - 06/2010
2	Immunotherapy 01/2015 - 09/2004
1	Adjuvant Chemotherapy 01/2023
1	Neoadjuvant Therapy 11/2020